Trigonella foenum graecum (fenugreek) seed extract as an antineoplastic agent

Phytother Res. 2001 May;15(3):257-9. doi: 10.1002/ptr.718.

Abstract

The antineoplastic effect of Trigonella foenum graecum seed extract has been evaluated in the Ehrlich ascites carcinoma (EAC) model in Balb-C mice. Intra-peritoneal administration of the alcohol extract of the seed both before and after inoculation of EAC cell in mice produced more than 70% inhibition of tumour cell growth with respect to the control. Treatment with the extract was found to enhance both the peritoneal exudate cell and macrophage cell counts. The extract also produced a significant antiinflammatory effect. We report here the antiinflammatory and antineoplastic effects, of Trigonella foenum graecum seed extract.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Ehrlich Tumor / chemically induced
  • Carcinoma, Ehrlich Tumor / prevention & control*
  • Carrageenan
  • Edema / chemically induced
  • Edema / prevention & control*
  • Mice
  • Mice, Inbred BALB C
  • Plant Extracts* / pharmacology
  • Plant Extracts* / therapeutic use
  • Plants, Medicinal*
  • Rats
  • Rats, Sprague-Dawley
  • Seeds
  • Trigonella

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Plant Extracts
  • fenugreek seed meal
  • Carrageenan